Keyword: David Hung

UPDATED: Pfizer buys Medivation for $81.50 a share

Move over Sanofi, your original $9.3 billion bid and even your second, sweetened offer has been blown out of the water by the $14 billion being put on the table by Pfizer--and Medivation’s CEO David Hung has decided that's his best bet and has taken the deal.